291 related articles for article (PubMed ID: 12371635)
21. Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever.
Kucuksahin O; Yildizgoren MT; Ilgen U; Ates A; Kinikli G; Turgay M; Erten S
Mod Rheumatol; 2017 Mar; 27(2):350-355. PubMed ID: 27328763
[TBL] [Abstract][Full Text] [Related]
22. Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment.
Bilgen SA; Kilic L; Akdogan A; Kiraz S; Kalyoncu U; Karadag O; Ertenli I; Dogan I; Calguneri M
J Clin Rheumatol; 2011 Oct; 17(7):358-62. PubMed ID: 21946459
[TBL] [Abstract][Full Text] [Related]
23. Long-term colchicine treatment in children with familial Mediterranean fever.
Zemer D; Livneh A; Danon YL; Pras M; Sohar E
Arthritis Rheum; 1991 Aug; 34(8):973-7. PubMed ID: 1859491
[TBL] [Abstract][Full Text] [Related]
24. Current trends in colchicine treatment in familial Mediterranean fever.
La Regina M; Ben-Chetrit E; Gasparyan AY; Livneh A; Ozdogan H; Manna R
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):41-6. PubMed ID: 24064013
[TBL] [Abstract][Full Text] [Related]
25. Vitamin B12 levels in familial Mediterranean fever patients treated with colchicine.
Gemici AI; Sevindik ÖG; Akar S; Tunca M
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):57-9. PubMed ID: 24064015
[TBL] [Abstract][Full Text] [Related]
26. Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics.
Grattagliano I; Bonfrate L; Ruggiero V; Scaccianoce G; Palasciano G; Portincasa P
Clin Pharmacol Ther; 2014 Jan; 95(1):89-97. PubMed ID: 23867542
[TBL] [Abstract][Full Text] [Related]
27. [Nephrotic syndrome in familial Mediterranean fever--effect of colchicine therapy].
Højberg AS; Mertz H
Ugeskr Laeger; 1995 Jul; 157(28):4035-7. PubMed ID: 7645081
[TBL] [Abstract][Full Text] [Related]
28. A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever.
Corsia A; Georgin-Lavialle S; Hentgen V; Hachulla E; Grateau G; Faye A; Quartier P; Rossi-Semerano L; Koné-Paut I
Orphanet J Rare Dis; 2017 Mar; 12(1):54. PubMed ID: 28302131
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of long-term treatment with intravenous colchicine for familial Mediterranean fever (FMF) refractory to oral colchicine.
Grossman C; Farberov I; Feld O; Livneh A; Ben-Zvi I
Rheumatol Int; 2019 Mar; 39(3):517-523. PubMed ID: 30604205
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment with anti-tumor necrosis factor (anti-TNF)-alpha of proteinuria in a patient with familial mediterranean fever (FMF) resistant to colchicine: anti-TNF drugs and FMF.
Erten S; Erten SF; Altunoglu A
Rheumatol Int; 2012 Apr; 32(4):1095-7. PubMed ID: 21431291
[TBL] [Abstract][Full Text] [Related]
31. [Fever of unknown origin and colchicine-sensitive amyloidosis: familial Mediterranean fever?].
Schneider W; Wehmeier A
Dtsch Med Wochenschr; 1989 Jun; 114(24):951-4. PubMed ID: 2731480
[TBL] [Abstract][Full Text] [Related]
32. Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever?
Erden A; Batu ED; Sarı A; Sönmez HE; Armagan B; Demir S; Fırat E; Bilginer Y; Bilgen SA; Karadağ Ö; Kalyoncu U; Kiraz S; Ertenli I; Özen S; Akdogan A
Clin Exp Rheumatol; 2018; 36(6 Suppl 115):97-102. PubMed ID: 30418112
[TBL] [Abstract][Full Text] [Related]
33. Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial.
Hashkes PJ; Spalding SJ; Giannini EH; Huang B; Johnson A; Park G; Barron KS; Weisman MH; Pashinian N; Reiff AO; Samuels J; Wright DA; Kastner DL; Lovell DJ
Ann Intern Med; 2012 Oct; 157(8):533-41. PubMed ID: 23070486
[TBL] [Abstract][Full Text] [Related]
34. Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine.
Ozen S; Bilginer Y; Aktay Ayaz N; Calguneri M
J Rheumatol; 2011 Mar; 38(3):516-8. PubMed ID: 21159830
[TBL] [Abstract][Full Text] [Related]
35. Colchicine-induced myopathy in a teenager with familial Mediterranean fever.
Sayarlioglu M; Sayarlioglu H; Ozen S; Erkoc R; Gul A
Ann Pharmacother; 2003 Dec; 37(12):1821-4. PubMed ID: 14632592
[TBL] [Abstract][Full Text] [Related]
36. Interferon-alpha as a treatment modality for colchicine- resistant familial Mediterranean fever.
Tweezer-Zaks N; Rabinovich E; Lidar M; Livneh A
J Rheumatol; 2008 Jul; 35(7):1362-5. PubMed ID: 18528960
[TBL] [Abstract][Full Text] [Related]
37. The prevention of amyloidosis in familial Mediterranean fever with colchicine.
Cabili S; Zemer D; Pras M; Aviram A; Sohar E; Gafni J
Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():709-11. PubMed ID: 3991564
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of nephrotic syndrome due to FMF amyloidosis with azathioprine: report of three Turkish cases.
Sayarlioglu H; Erkoc R; Sayarlioglu M; Dogan E; Soyoral Y
Rheumatol Int; 2006 Dec; 27(2):197-9. PubMed ID: 16944160
[TBL] [Abstract][Full Text] [Related]
39. Correction of a suppressor cell deficiency in familial Mediterranean fever by colchicine.
Ilfeld D; Weil S; Kuperman O
Clin Exp Immunol; 1981 Oct; 46(1):77-81. PubMed ID: 6461454
[TBL] [Abstract][Full Text] [Related]
40. Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial.
Ben-Zvi I; Kukuy O; Giat E; Pras E; Feld O; Kivity S; Perski O; Bornstein G; Grossman C; Harari G; Lidar M; Livneh A
Arthritis Rheumatol; 2017 Apr; 69(4):854-862. PubMed ID: 27860460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
